|
|
|
|
|
|
|
|
|
|
Exceptional Bioscience Facility
25 Crestridge Drive, Suwanee Georgia, USA
Equis is pleased to offer a state-of-the-art plug and play bioscience facility currently being used for production of nucleic acid diagnostic test kits and the associated research and development.
- Northeast Metro Atlanta Location off Interstate 85 in Horizon Business Park
- 99,822 SF Bioscience Facility
- 23,000 SF Lab/Research Area
- 8,200 SF Clean Room Area
- 24,200 SF Office Area
- 11,300 SF Common/Amenities Area
- 14,200 SF Support Area
- 19,000 SF Expansion Area
- State-of-the-Art Building Systems, Fixtures and Equipment
- Constructed in 2000
- Validated Facility, Meets ISO Standards, Meets FDA Requirements, Maintained to GMP
- Standards
- Class Rated (100K, 10K, 100) Clean Rooms
- Dual Redundant Building Systems
- Easily Expandable or Convertible
- Aggressive Lease Rate and Terms
- Remaining Term through March 2010
- Available January 2004
Lab and Research Facilities
- 15,000 SF of Lab/Research Space
- 8,000 SF of Quality Assurance Lab Space
Clean Suite
- State of the art clean suites currently used for the preparation, completion and filling of viral testing and diagnostics kits and materials with zero contamination tolerances. All space is compatible with 21CFR911 standards and is suitable for biotech, genetic, pharmaceutical, information technology, medical devices and high-grade food uses.
Packaging Room
- 3,200 SF Labeling and Packaging Area
- SS Worktables & Storage Cabinets
- Metrology Room
Building Entrance
- State of the Art Building Systems, Fixtures and Equipment
- Constructed in 2000
- Validated Facility, Meets ISO Standards, Meets FDA Requirements, Maintained to GMP Standards
Lobby and Reception
- Light Maple Paneled Lobby with Matching Built In Receptionist Area
- State of the Art Executive Board Room
- Wellness Center
- Cafeteria
- 3 Break Rooms
- 7 M's/W's Restroom Areas Conveniently Distributed Throughout Space
25 Crestridge Drive, Suwanee Georgia, USA
|
|
Back To DeviceSpace Real Estate Listings
|
 |
 |
|
|
|
|
|
|
|
|